Review, approval, and marketing of biosimilars in the United States - Part 1

Safety and regulatory issues

Amber W. Aagaard, Serena Purdy, Sean Philpott

Research output: Contribution to Newspaper/Magazine/WebsiteArticle

6 Citations (Scopus)
Original languageEnglish
Pages12-20
Number of pages9
Volume8
No.11
Specialist publicationBioProcess International
Publication statusPublished - Dec 2010
Externally publishedYes

Cite this